Study guide
5.4 Toxicology and Antidotes
NABP FPGEE Foreign Pharmacy Graduate Equivalency Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the FPGEE 1.2 How to Use This Study Guide
2 Chapter 2: Foundational Biomedical Sciences I
2.1 Anatomy 2.2 Physiology 2.3 Biochemistry
3 Chapter 3: Foundational Biomedical Sciences II
3.1 Medical Microbiology 3.2 Immunology 3.3 Pathophysiological Bases of Diseases
4 Chapter 4: Pharmaceutical Calculations, Compounding, and Medicinal Chemistry
4.1 Pharmaceutical Calculations 4.2 Extemporaneous Compounding 4.3 Physicochemical Properties, ADME, and Drug Metabolism Pathways 4.4 Structure-Activity Relationships and Drug-Receptor Interactions
5 Chapter 5: Pharmacology and Toxicology
5.1 Pharmacodynamics and Dose-Response 5.2 Mechanisms of Action of Drugs and Biologics 5.3 Adverse Effects, Side Effects, and Drug Interactions 5.4 Toxicology and Antidotes
6 Chapter 6: Pharmaceutics, Biopharmaceutics, and Pharmacokinetics
6.1 Dosage Forms, Drug Delivery, and Dissolution 6.2 Stability, Shelf-Life, and Manufacturing 6.3 ADME Rates, Half-Lives, and Compartment Models 6.4 Bioavailability, Bioequivalence, Biosimilars, and Pharmacogenomics
7 Chapter 7: Pharmacy Law, Ethics, and Health Care Systems
7.1 Pharmacy Law and Regulations 7.2 Ethics and Regulatory/Oversight Organizations 7.3 US Health Care Systems 7.4 Pharmacoeconomics
8 Chapter 8: Public Health, Practice Management, and Biostatistics
8.1 Pharmacoepidemiology, Population-Based Care, and Public Health 8.2 Practice Management 8.3 Continuous Quality Improvement, Risk Management, and Inventory Control 8.4 Biostatistics and Research Methods
9 Chapter 9: Professional Communication and Behavioral Aspects
9.1 Professional Communication 9.2 Social and Behavioral Aspects of Practice
10 Chapter 10: Clinical Sciences I — Pathophysiology and Patient Assessment
10.1 Clinical Pathophysiology: Cardiovascular and Endocrine 10.2 Clinical Pathophysiology: Respiratory, GI, Renal, and Other Systems 10.3 Patient Data Collection 10.4 Patient Data Assessment 10.5 Patient-Care Decision Making, Therapy Recommendations, and Education
11 Chapter 11: Clinical Sciences II — Patient Safety, Prevention, and Personalized Care
11.1 Patient Safety: Drug Interactions and Toxicity 11.2 Drug-Induced Disease and Drug Use Disorders 11.3 Disease Prevention 11.4 Personalized Medicine
12 Chapter 12: Clinical Sciences III — Evidence-Based Practice
12.1 Practice Guidelines and Drug Information 12.2 Clinical Trial Evaluation and Information Source Reliability
13 Chapter 13: Clinical Sciences IV — Self-Care and Natural Products
13.1 Self-Care and Natural Products
5.4 Toxicology and Antidotes
Key Takeaways Explain This Topic AI
NOAEL is the highest exposure without observed adverse effect and LOAEL is the lowest exposure with a detectable adverse effect; both anchor regulatory risk assessment.
Xenobiotic metabolism may detoxify or bioactivate a compound — acetaminophen's NAPQI, methanol's formic acid, and ethylene glycol's oxalic acid are classic bioactivation toxins.
Antidote selection depends on the agent, mechanism, and time since exposure; naloxone for opioids, N-acetylcysteine for acetaminophen, and fomepizole for toxic alcohols are high-yield pairings.
Decontamination and enhanced elimination — activated charcoal, gastric lavage, whole-bowel irrigation, hemodialysis, urinary alkalinization — are adjuncts whose use depends on agent properties and time window.
The Poison Prevention Packaging Act requires child-resistant packaging for hazardous household substances, and poison control centers (1-800-222-1222) should guide management of suspected poisoning.
Last updated: July 2026
Toxicology Principles: NOAEL, LOAEL, and Dose-Response
Toxicology applies the dose-response framework to adverse effects. The NOAEL (No Observed Adverse Effect Level) is the highest exposure producing no detectable adverse effect in animal studies; the LOAEL (Lowest Observed Adverse Effect Level) is the lowest exposure producing a detectable adverse effect. These thresholds inform reference doses and regulatory limits. The margin of safety in animal-to-human extrapolation incorporates uncertainty factors (typically 10-fold for interspecies differences and 10-fold for human variability).
Acute toxicity results from a single or short-duration exposure, while chronic toxicity arises from repeated lower-dose exposure (e.g., lead neurotoxicity, methotrexate hepatic fibrosis). Both follow dose-response relationships, but chronic toxicity often involves cumulative tissue injury and bioaccumulation.
Xenobiotic Metabolism: Detoxification and Bioactivation
Xenobiotics are foreign chemicals metabolized primarily in the liver via phase I (oxidation, reduction, hydrolysis — mostly CYP450) and phase II (conjugation — glucuronidation, sulfation, acetylation, glutathione). Metabolism usually detoxifies, but some compounds undergo bioactivation to reactive metabolites that cause injury:
Acetaminophen — minor CYP2E1 oxidation forms NAPQI , a reactive quinone that depletes glutathione and covalently binds hepatocytes. Overdose overwhelms glutathione reserves, producing centrilobular necrosis.
Methanol — alcohol dehydrogenase oxidizes methanol to formaldehyde and then formic acid , which causes retinal toxicity and severe metabolic acidosis.
Ethylene glycol — alcohol dehydrogenase produces glycolate and oxalic acid , the latter precipitating as calcium oxalate crystals in renal tubules, causing acute kidney injury and severe acidosis.
The therapeutic strategy for toxic alcohols is to block alcohol dehydrogenase with fomepizole (or ethanol) to prevent formation of the toxic metabolite.
Organ-Specific Toxic Mechanisms and Antidotes
- Poisoning or overdose Antidote Mechanism
- Acetaminophen N-acetylcysteine Replenishes glutathione; detoxifies NAPQI; most effective within 8 hours
Opioids (morphine, heroin, fentanyl) Naloxone Competitive mu receptor antagonist; reverses respiratory depression
Benzodiazepines Flumazenil Competitive GABA-A antagonist; risk of seizure in chronic users
Beta-blockers and calcium-channel blockers Calcium (chloride or gluconate), glucagon, high-dose insulin/euglycemia Overcome channel blockade; glucagon increases cAMP and contractility; HDI enhances myocardial carbohydrate metabolism
Digoxin Digoxin Fab antibody fragments (DigiFab) Bind digoxin in plasma; shift drug from tissue receptors into blood for renal elimination
Anticholinergics (atropine, antihistamines) Physostigmine Acetylcholinesterase inhibitor that crosses the blood-brain barrier; reverses central and peripheral effects
Cholinergics / organophosphates (nerve agents, pesticides) Atropine plus pralidoxime (2-PAM) Atropine blocks muscarinic effects; 2-PAM reactivates acetylcholinesterase before the enzyme-phosphate complex ages
Iron Deferoxamine Chelates iron; forms ferrioxamine excreted in urine (vin rose urine)
Lead (acute and chronic) Succimer (DMSA) oral; EDTA or dimercaprol in severe cases Chelation; dimercaprol for encephalopathy, EDTA for blood lead reduction, succimer for moderate poisoning
Methanol and ethylene glycol Fomepizole or ethanol, plus hemodialysis Block alcohol dehydrogenase to prevent toxic metabolites; dialysis removes parent alcohol and metabolites
Heparin (unfractionated) Protamine sulfate Positively charged protein that binds negatively charged heparin, neutralizing anticoagulant effect (1 mg per 100 units heparin)
Warfarin Vitamin K1 (phytomenadione) plus four-factor prothrombin complex concentrate for serious bleeding Replenishes vitamin K-dependent factors; PCC provides immediate replacement
Cyanide Hydroxocobalamin or sodium thiosulfate (plus sodium nitrite in the traditional kit) Hydroxocobalamin binds cyanide to form cyanocobalamin (vitamin B12); thiosulfate donates sulfur to convert cyanide to thiocyanate via rhodanese
Carbon monoxide 100% oxygen; hyperbaric oxygen for severe poisoning Oxygen displaces CO from hemoglobin; hyperbaric oxygen accelerates dissociation and reduces neurologic sequelae
Methotrexate Leucovorin (folinic acid) Bypasses dihydrofolate reductase blockade; rescues normal cells (time-sensitive)
Heparin-induced thrombocytopenia Argatroban or bivalirudin (direct thrombin inhibitors) Provide anticoagulation without heparin exposure
Decontamination and Enhanced Elimination
Decontamination reduces absorption after exposure:
Activated charcoal — adsorbs most drugs; most effective within 1 hour of ingestion; dose 1 g/kg. Not useful for alcohols, metals, lithium, or hydrocarbons.
Gastric lavage — rarely used; considered only within 1 hour of a life-threatening ingestion when the airway is protected.
Whole-bowel irrigation — polyethylene glycol solution for sustained-release drugs, iron, lithium, or body-packing ("packers").
Skin and ocular irrigation — copious water or saline for corrosives and pesticides.
Enhanced elimination accelerates removal of absorbed drug:
Hemodialysis — effective for small, water-soluble, low-protein-bound, low-Vd drugs (salicylates, methanol, ethylene glycol, lithium, metformin, valproate, carbamazepine).
Urinary alkalinization — intravenous sodium bicarbonate to maintain urine pH > 7.5 traps weak acids (salicylates, methotrexate, phenobarbital) in the tubule.
Hemoperfusion — rarely used; effective for theophylline, carbamazepine, and valproate.
The decision to use enhanced elimination depends on the agent's properties (volume of distribution, protein binding), the patient's clinical status, and the availability of supportive care.
Poison Prevention and Public Health
The Poison Prevention Packaging Act (PPPA, 1970) requires child-resistant packaging for hazardous household substances, including most oral prescription drugs. Compliance has markedly reduced pediatric poisoning deaths. Poison control centers (US nationwide hotline 1-800-222-1222) provide 24/7 expert consultation for poisonings and should be contacted early in the management of any serious exposure. Pharmacists play a central role in patient education, identifying at-risk products in the home, and counseling caregivers on safe storage.